Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.

@article{BaniSadr2008SevereWL,
  title={Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.},
  author={F Bani-Sadr and Nathanael Lapidus and J. Melchior and Isabelle Ravaux and Maryse Bensalem and Isabelle Rosa and P Cacoub and Stanislas Pol and Christian Perronne and Fabrice Carrat},
  journal={Journal of viral hepatitis},
  year={2008},
  volume={15 4},
  pages={255-60}
}
Weight loss is reported by more than 20% of hepatitis C virus (HCV)-monoinfected patients treated with the peg-interferon (peg-IFN) and ribavirin combination. The aim of this study was to determine the incidence and risk factors of severe weight loss (> or =10%) in human immunodeficiency virus (HIV) / HCV-coinfected patients participating in a randomized… CONTINUE READING